# NHS Framework Colorectal Cancer Drugs \(See description below\)

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Amgen Ltd
- Award value: £75,000,000
- Award date: 13 November 2020
- Published: 1 December 2020
- Contract start: 1 December 2020
- Contract end: 30 November 2022
- Stage: awarded
- Procurement category: goods
- Notice ID: 21568ef8-4d67-4fc9-90bd-23e8c0f323da-397439
- OCID: ocds-b5fd17-9a3056a9-6b7f-4b93-8ee8-f0125b6dd420

## Description

NHS Framework for the supply of drugs licensed specifically to target epidermal growth factor receptor \(EGFR\)-expressing, RAS wild-type metastatic colorectal cancer

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab](/contracts/ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30): NHS England
- [NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024](/contracts/ocds-b5fd17-f8f31612-30fe-46cd-8155-9f4881ec58c8): NHS England
- [NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023](/contracts/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/21568ef8-4d67-4fc9-90bd-23e8c0f323da-397439)